ProfileGDS5822 / ILMN_3162242
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 37% 33% 24% 33% 44% 56% 53% 58% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 117.437
GSM1276600PDAC Late Ablation Control 218.233
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 112.124
GSM1276603PDAC Late Ablation 216.133
GSM1276604PDAC Late Ablation 321.244
GSM1303940PDAC Late Ablation_anti-CTLA4 125.556
GSM1303941PDAC Late Ablation_anti-CTLA4 227.753
GSM1303942PDAC Late Ablation_anti-CTLA4 333.858